Detalles de la búsqueda
1.
Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress.
J Mol Med (Berl)
; 81(10): 664-73, 2003 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-12928788
2.
Induction chemotherapy followed by concomitant chemoradiation therapy in advanced head and neck cancer: a phase II study for organ-sparing purposes evaluating feasibility, effectiveness and toxicity.
Int J Oncol
; 20(2): 419-27, 2002 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-11788911
3.
The impact of different antioxidant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites: correlation with disease progression.
Free Radic Res
; 37(2): 213-23, 2003 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-12653210
4.
Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer.
Oncol Rep
; 9(3): 661-70, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-11956647
5.
Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy.
Oncol Rep
; 9(4): 887-96, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-12066227
6.
Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
Oncol Rep
; 10(1): 197-206, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12469169
7.
Six-week induction chemotherapy followed by concomitant chemoradiation therapy in stage IV head and neck cancer: a phase II study with organ-sparing purposes.
Oncol Rep
; 10(3): 759-66, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12684655
8.
Reactive oxygen species, antioxidant mechanisms, and serum cytokine levels in cancer patients: impact of an antioxidant treatment.
J Environ Pathol Toxicol Oncol
; 22(1): 17-28, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12678402
9.
Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status.
Int J Cancer
; 98(1): 84-91, 2002 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11857390
Resultados
1 -
9
de 9
1
Próxima >
>>